IT Software Tools for Life Science and Drug Discovery R&D
Published By: Fuji-Keizai USA, Inc.
June 2009
R98-214
Hard Copy Mail Delivery $1,495.00 (Subject to Shipping Charges)
Department License Fulfilled By Publisher $2,295.00
Global Site License Fulfilled by Publisher $3,495.00
Description
This report examines the growing worldwide IT software and services market for the life science and drug discovery R&D community. The broad and high-level study takes a business focus and analyzes this interesting vertical market that supports key biomedical advancements.
The emergence of big-budget, life science and drug discovery R&D initiatives sponsored by world governments and other players, combined with the rapid deployments of many types of new analytical instruments has created an incredible set of drug discovery opportunities and challenges for academic labs, R&D institutes and drug making companies alike. Their enormous data output is driving the need to acquire key IT software tools and service solutions even in a major recession.
Big pharma and biotech companies continue to suffer from high R&D costs, drug patent expirations, lower new drug product output, more competition, regulatory challenges and other issues. A growing number of drug makers have turned to reorganizing their business models and are using powerful computer infrastructure and IT software solutions that will help transform their companies with next generation R&D capabilities. They hope to shorten their drug R&D timelines and reduce costs.
The study analyzes the market for IT software tools and services that enable life science and drug R&D. The report segments the software tools and services market by key R&D technology areas that map to drug R&D functions. The R&D tools, such as DNA arrays, next-generation sequencing, cell analysis, biomarkers, knowledge management, ELNs, LIMS and others are discussed.
This report discusses the interesting IT software topics with key findings. The study estimates that the worldwide IT software and services market for life science and drug R&D will reach $1.8 billion in 2009, with a strong growth rate. The research report is for marketers, business development, top executives, investors, VCs, consultants, R&D managers, or entrepreneurs. The report discusses a number of interesting customer case studies and includes 21 company profiles. This report uses 41 figures and tables to illustrate the findings. The study features many convenient tables that help the reader scan the details of key trends, market segmentation, revenue outlook, products, key customers and the like.
|
Table of Contents
- 1. Overview of IT Software Tools for Life Science & Drug Discovery R&D
- 1.1 Market Ecosystem of IT Software Tools for Life Science & Drug Discovery R&D
- 1.2 Industry Drug Discovery R&D Applications
- 1.2.1 Life Science and Drug Discovery R&D Steps
- 1.2.2 Industrial Scale Drug R&D Factories
- 1.2.3 Instrumentation Advances Are Driving Need for More IT Solutions
- 1.3 IT Software Tools, Technologies, Equipment & Products for R&D
- 1.3.1 R&D IT Infrastructure
- 1.3.2 R&D IT Storage Systems Infrastructure
- 1.3.3 R&D IT Application Software
- 2. Activities of IT Software Tools by Key Life Science R&D Segments
- 2.1 Overview of IT Software Tools by Key Life Science R&D Segments
- 2.2 Software Products by Technology Segments
- Table 1 Technology Segment/Category/Software Name/Software Vendor/Customers
- T1-1 DNA Array Analysis
- T1-2 Next Generation Sequecing
- T1-3 Epigenetics Analysis
- T1-4 Proteomics
- T1-5 Cell-Based Analysis
- T1-6 RNAi Analysis
- T1-7 Molecular Diagnostics & Testing
- T1-8 Genetic Biomarker R&D
- T1-9 R&D Data Integration
- T1-10 R&D Knowledge Management & Collaboration
- T1-11 Others: R&D WorkFlow; LIMS; ELNs, etc.
- 2.3 Software Products by Technology Segment & Customer Organization
- Table 2 Technology Segment/Category/Customer Organization/Software Name/Vendor
- T2-1 DNA Array Analysis
- T2-2 Next Generation Sequencing
- T2-3 Epigenetic Analysis
- T2-4 Proteomics
- T2-5 Cell-Based Analysis
- T2-6 RNAi Analysis
- T2-7 Molecular Diagnostics & Testing
- T2-8 Genetic Biomarker R&D
- T2-9 R&D Data Integration
- T2-10 R&D Knowledge Management & Collaboration
- T2-11 Others: R&D WorkFlow; LIMS; ELNs, etc
- 2.4 Software Products by Technology Segment & Services Providers/ Outsourcers
- Table 3 Technology Segment/Category/Service Provider/Outsourcer/Service Detail
- T3-1 DNA Array Analysis
- T3-2 Next Generation Sequencing
- T3-3 Epigenetic Analysis
- T3-4 Proteomics
- T3-5 Cell-Based Analysis
- T3-6 RNAi Analysis
- T3-7 Molecular Diagnostic & Testing
- T3-8 Genetic Biomarker R&D
- T3-9 R&D Data Integration
- T3-10 R&D Knowledge Management & Collaboration
- T3-11 Others: R&D WorkFlow; LIMS; ELNs, Etc.
- 3. Case Studies
- 3.1 Hospital for Sick Children Research Institute and Genologics
- 3.1.1 Need for a New Informatics Software Solution
- 3.1.2 The Solution That Was Selected
- 3.1.3 Technology Review
- 3.1.4 Results of Solution
- 3.2 Human Genome Sequencing Center at the Baylor College of Medicine and Data Storage Solution
- 3.2.1 Need for an IT Storage Systems Solution
- 3.2.2 The Solution That Was Selected
- 3.2.3 Technology Review
- 3.2.4 Results of Solution
- 3.3 Eli Lilly and Discovery Research Knowledge Management Solution
- 3.3.1 Need for a Software Solution
- 3.3.2 The Solution That Was Selected
- 3.3.3 Technology Review
- 3.3.4 Results of Solution
- 3.4 Sanofi-Aventis and In Silico Drug Discovery
- 3.4.1 Need for a Software Solution
- 3.4.2 The Software Solution That Was Selected
- 3.4.3 Technology Review
- 3.4.4 Results of Solution
- 3.5 Biogen Idec, Inc. and Tibco Spotfire DecisionSite
- 3.5.1 Need for a Software Solution
- 3.5.2 The Solution That Was Selected
- 3.5.3 Technology Review
- 3.5.4 Results of Solution
- 4. WW Software Tools & IT Services Market Forecast for Life Science and Drug R&D
- 4.1 Methodology Used for This Report
- 4.1.1 Methodology
- 4.1.2 Definitions
- 4.1.3 Research Information Sources
- 4.2 WW Market Forecast (Total)
- 4.3 WW Market Forecast by Technologies
- 4.3.1 Revenues by Technology Segment, 2008-2013
- 4.3.2 Market Shares by Technology Segments, 2008 & 2013
- 4.4 WW Market Forecast by Customer Organization Segments
- 4.4.1 Revenues by Customer Organization Segments, 2008-2013
- 4.4.1.1 Academic, Government
- 4.4.1.2 R&D Service Provider
- 4.4.1.3 Pharma, Biotech
- 4.4.1.4 Other
- 4.4.2 Market Shares by Customer Organization Segments, 2008 & 2013
- 4.5 WW Market Forecast by Regions
- 4.5.1 Revenues by Regions, 2008-2013
- 4.5.1.1 US
- 4.5.1.2 Europe
- 4.5.1.3 Asia Pacific
- 4.5.1.4 ROW
- 4.5.2 Market Shares by Region, 2008 & 2013
- 5. Company Profiles: IT Software Tools
- 5.1 Equipment
- 5.1.1 Affymetrix, Inc.
- 5.1.2 Agilent Technologies, Inc., BAM/LS
- 5.1.3 BlueArc Corporation
- 5.1.4 Isilon Systems, Inc.
- 5.1.5 Life Technologies, Inc.
- 5.1.6 ThermoFisher Scientific Inc.
- 5.2 Services
- 5.2.1 BioTeam, Inc.
- 5.2.2 Cogenics (Div. Of Clinical Data)
- 5.2.3 Complete Genomics, Inc.
- 5.2.4 GATC Biotech AG
- 5.2.5 Genpathway, Inc.
- 5.2.6 Ocimum Biosolutions Ltd.
- 5.3 Software
- 5.3.1 Accelrys, Inc.
- 5.3.2 CLC bio 119
- 5.3.3 DNASTAR, Inc.
- 5.3.4 Entelos, Inc.
- 5.3.5 Gene Codes Corporation
- 5.3.6 GeneGo, Inc.
- 5.3.7 Genomatix Software GmbH
- 5.3.8 GenomeQuest, Inc.
- 5.3.9 Symyx Technologies,Inc.
- 6. Conclusions
- 7. Addendum: Revenue Forecast Outlook Detail Tables by Technology Segements
- 8. Appendix 1
- 8.1 Key Life Science R&D Centers
- 8.2 Selected Company Links
- 9. Appendix 2
- 9.1 Glossary - Life Science Terms
- List of Tables
- Table 1 Technology Segment/Category/Software Name/Software Vendor/Customers
- T1-1 DNA Array Analysis
- T1-2 Next Generation Sequecing
- T1-3 Epigenetics Analysis
- T1-4 Proteomics
- T1-5 Cell-Based Analysis
- T1-6 RNAi Analysis
- T1-7 Molecular Diagnostics & Testing
- T1-8 Genetic Biomarker R&D
- T1-9 R&D Data Integration
- T1-10 R&D Knowledge Management & Collaboration
- T1-11 Others: R&D WorkFlow; LIMS; ELNs, etc.
- Table 2 Technology Segment/Category/Customer Organization/Software Name/Vendor
- T2-1 DNA Array Analysis
- T2-2 Next Generation Sequecing
- T2-3 Epigenetics Analysis
- T2-4 Proteomics
- T2-5 Cell-Based Analysis
- T2-6 RNAi Analysis
- T2-7 Molecular Diagnostics & Testing
- T2-8 Genetic Biomarker R&D
- T2-9 R&D Data Integration
- T2-10 R&D Knowledge Management & Collaboration
- T2-11 Others: R&D WorkFlow; LIMS; ELNs, etc.
- Table 3 Technology Segment/Category/Service Provider/Outsourcer/Service Detail
- T3-1 DNA Array Analysis
- T3-2 Next Generation Sequecing
- T3-3 Epigenetics Analysis
- T3-4 Proteomics
- T3-5 Cell-Based Analysis
- T3-6 RNAi Analysis
- T3-7 Molecular Diagnostics & Testing
- T3-8 Genetic Biomarker R&D
- T3-9 R&D Data Integration
- T3-10 R&D Knowledge Management & Collaboration
- T3-11 Others: R&D WorkFlow; LIMS; ELNs, etc.
- Table 4 Rackable Compute Servers
- Table 5 Rackable Storage Servers
- Table 6 Total WW Market Forecast, 2008-2013
- Table 7 WW Revenues by Technology Segments, 2008-2013
- Table 8 WW Market Shares by Technology Segments, 2008 & 2013
- Table 9 WW Revenues by Customer Org. Segments, 2008-2013
- Table 10 WW Market Shares by Customer Org. Segments, 2008 & 2013
- Table 11 WW Revenues by Regions, 2008-2013
- Table 12 WW Market Shares by Regions, 2008 & 2013
- Table 13 Examples of Pharma Knowledge Management Systems
- Table 14 Selected Pre-Competitive R&D Information Sharing Arrangements
- Table 15 Addendum: DNA Array Analysis Revenue Detail, 2008-2013
- Table 16 Addendum: Next-Generation Sequencing Analysis Revenue Detail, 2008-2013
- Table 17 Addendum: Epigenetic Analysis Revenue Detail, 2008-2013
- Table 18 Addendum: Proteomics Analysis Revenue Detail, 2008-2013
- Table 19 Addendum: Cell-Based Analysis Revenue Detail, 2008-2013
- Table 20 Addendum: Genetic Biomarker R&D Revenue Detail, 2008-2013l
- Table 21 Addendum: RNAi Analysis Revenue Detail, 2008-2013
- Table 22 Addendum: Molecular Diagnostics Revenue Detail, 2008-2013
- Table 23 Addendum: R&D Data Integration; Content Mgt. Revenue Detail, 2008-2013
- Table 24 Addendum: R&D Knowledge Mgt. & Collab. Revenue Detail, 2008-2013
- Table 25 Addendum: R&D Other: Workflows, LIMS, ELNs Revenue Detail, 2008-2013
- Table 26 Large International Life Science R&D Centers
- Table 27 Selected Companies By Product Area
- Table 28 Glossary - Life Science Terms
- List of Illustrations
- Figure 1 The IT Software Tools for Life Science & Drug Discovery R&D Market Ecosystem
- Figure 2 The Drug Research and Development Path to Final Approval
- Figure 3 The “Drug Discovery” Steps of the Drug R&D Process
- Figure 4 Rackable C1001 Compute Server
- Figure 5 Rackable S3012 Storage Server
- Figure 6 Mobius Quick Search - All Data View
- Figure 7 Tibco SpotFire DecisionSite
- Figure 8 Total WW Market Forecast, 2008-2013
- Figure 9 WW Market Revenues by Technology Segments, 2008-2013
- Figure 10 WW Market Shares by Technology Segments, 2008 & 2013
- Figure 11 WW Market Revenues by Customer Org. Segments, 2008-2013
- Figure 12 WW Market Shares by Customer Org. Segments, 2008 & 2013
- Figure 13 WW Market Revenues By Regions, 2008-2013
- Figure 14 WW Market Shares by Regions, 2008 & 2013
|
Order Form * Please reference product number R98-214 when ordering or inquiring.
MindBranch, Inc.,
131 Ashland St., Suite 200 North Adams, MA 01247
tel: 800-774-4410
fax: +1-413-664-9791
www.mindbranch.com
|
